# The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants

> **NCT04541771** · PHASE2 · UNKNOWN · sponsor: **Children's Hospital and Institute of Child Health, Multan** · enrollment: 120 (estimated)

## Conditions studied

- Necrotizing Enterocolitis
- Sepsis

## Interventions

- **DRUG:** Lactobacillus Reuteri DSM 17938
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04541771
- **Lead sponsor:** Children's Hospital and Institute of Child Health, Multan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10
- **Primary completion:** 2020-12
- **Final completion:** 2021-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04541771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04541771, "The Role of Lactobacillus Reuteri in Preventing Necrotizing Enterocolitis (NEC) in Pre-term Infants". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04541771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*